CLASS III Food recall · Reported 20 Mar 2019 · FDA Enforcement Report

Hikari Enjuku Koji Miso Mutenka recalled by Hikari Miso International

Hikari Miso International is recalling Hikari Enjuku Koji Miso Mutenka, distributed in California. The recall was initiated on 1 Feb 2019 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesBest Before 28.OCT. 2019
Quantity recalled224 cases ( 8 tubs per case)

Do not eat it. Return it to the store for a refund or throw it away. If you have symptoms after eating it, contact a doctor.

Recall details

Recall number
F-1189-2019
FDA event ID
82306
Recalling firm
Hikari Miso International, Torrance, CA
Classification
Class III
Status
Terminated
Recall initiated
1 Feb 2019
FDA classified
25 Mar 2019
Reported
20 Mar 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Undeclared Soy
Product category
Tofu & Soy

Timeline

1 Feb 2019Recall initiated by company
20 Mar 2019Published in enforcement report+47 days
25 Mar 2019Classified by FDA+5 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Miso product manufactured in Japan was distributed in US with no English labeling and therefore soy beans not properly declared on label as an allergen.

Product as listed by the FDA

Hikari Enjuku Koji Miso Mutenka; 26.6 oz. plastic tub with lid. UPC 4 905663 003007

Where it was distributed

One distributor in CA only

California

Questions about this recall

Why was it recalled?

Miso product manufactured in Japan was distributed in US with no English labeling and therefore soy beans not properly declared on label as an allergen.

Which lots are affected?

Best Before 28.OCT. 2019

Where was it sold?

One distributor in CA only

What should I do if I have it?

Do not eat it. Return it to the store for a refund or throw it away. If you have symptoms after eating it, contact a doctor.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Tofu & Soy recalls

All 26